Key facts
- Oli (Therapeutic Devices)’s last known valuation is $6.5M (Jun 2025).
- It has raised $1.1M; the latest was Seed Round ($700K) in Jun 2025.
- Notable investors include SOSV, HAX, BoxOne Ventures, Verge Capital Management, Innovation and Technology — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Oli (Therapeutic Devices)
- ·The full record, as it builds
Funding rounds
No funding rounds for Oli (Therapeutic Devices) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Oli (Therapeutic Devices)
Developer of a portable dialysis system designed for end-stage kidney patients to receive treatment anywhere. The company's system features a compact, user-friendly design powered by novel sorbent technology, replacing bulky, complex machines, enabling patients to maintain mobility, independence and an improved quality of life while accelerating regulatory approval through initial clinical deployment.
- Sector
- Healthcare
- HQ
- North Brunswick, NJ, United States
- Founded
- 2021
- Employees
- 4
- Website
- oli.inc/
- Ownership
- Privately Held (backing)
Oli (Therapeutic Devices) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Oli (Therapeutic Devices) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Oli (Therapeutic Devices) in its N-PORT filings yet. We sweep new filings monthly.